Sun-Dong Jang

Title: Sun-Dong Jang: Innovator in Zika Virus Research

Introduction

Sun-Dong Jang is a prominent inventor based in Chungcheongbuk-do, South Korea. He has made significant contributions to the field of virology, particularly in the development of vaccines against the Zika virus. His innovative work has the potential to enhance public health responses to viral outbreaks.

Latest Patents

Sun-Dong Jang holds a patent for a recombinant antigen derived from the Zika virus E protein. This invention relates to a polynucleotide encoding Zika virus E protein domain III, which can be used to create a DNA vaccine composition. The vaccine aims to induce an immune response to the Zika virus by effectively expressing the Zika virus antigen protein. Additionally, the patent includes a neutralizing antibody against the Zika virus, which is obtained using the polynucleotide, along with a method for preparing this antibody.

Career Highlights

Sun-Dong Jang is affiliated with the Korea Center for Disease Control and Prevention. His work at this institution underscores his commitment to advancing public health through innovative research and development. His contributions are vital in the ongoing efforts to combat viral diseases.

Collaborations

Sun-Dong Jang has collaborated with notable colleagues, including You-Jin Kim and Hyun Ju In. These partnerships enhance the research efforts and broaden the impact of their findings in the scientific community.

Conclusion

Sun-Dong Jang's work in developing a recombinant antigen for the Zika virus represents a significant advancement in vaccine research. His innovative approach and collaboration with fellow researchers contribute to the ongoing fight against viral diseases.